Health News Danish Drugmaker Novo Nordisk Bets $145 Million On Post-Brexit UK Science January 31, 2017 0 Comment Novo Nordisk, the world’s top maker of diabetes drugs, is investing 115 million pounds ($145 million) in a new research centre in Britain, undeterred by Brexit.
